Cargando…
CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases
INTRODUCTION: Bisphosphonates (BPs) are bone-protecting osteoclast inhibitors, typically used in the treatment of osteoporosis and skeletal complications of malignancies. When given in the adjuvant setting, these drugs may also prevent relapses and prolong overall survival in early breast cancer (EB...
Autores principales: | Petruk, Nataliia, Siddiqui, Arafat, Tadayon, Sina, Määttä, Jorma, Mattila, Pieta K., Jukkola, Arja, Sandholm, Jouko, Selander, Katri S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390692/ https://www.ncbi.nlm.nih.gov/pubmed/37533856 http://dx.doi.org/10.3389/fimmu.2023.1179022 |
Ejemplares similares
-
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Petruk, Nataliia, et al.
Publicado: (2021) -
Toll-Like Receptor 9 in Breast Cancer
por: Sandholm, Jouko, et al.
Publicado: (2014) -
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer
por: TUOMELA, JOHANNA, et al.
Publicado: (2013) -
Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo
por: Sandholm, Jouko, et al.
Publicado: (2016) -
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
por: VÄISÄNEN, MARJA-RIITTA, et al.
Publicado: (2013)